• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

绝经后妇女的内脏脂肪与促炎的肠道微生物组和免疫原性代谢内毒素血症有关。

Visceral adiposity in postmenopausal women is associated with a pro-inflammatory gut microbiome and immunogenic metabolic endotoxemia.

机构信息

Department of Surgery, Wake Forest University School of Medicine, Winston-Salem, NC, 27157, USA.

Department of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, NC, 27157, USA.

出版信息

Microbiome. 2024 Oct 4;12(1):192. doi: 10.1186/s40168-024-01901-1.

DOI:10.1186/s40168-024-01901-1
PMID:39367431
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11453046/
Abstract

BACKGROUND

Obesity, and in particular abdominal obesity, is associated with an increased risk of developing a variety of chronic diseases. Obesity, aging, and menopause are each associated with differential shifts in the gut microbiome. Obesity causes chronic low-grade inflammation due to increased lipopolysaccharide (LPS) levels which is termed "metabolic endotoxemia." We examined the association of visceral adiposity tissue (VAT) area, circulating endotoxemia markers, and the gut bacterial microbiome in a cohort of aged postmenopausal women.

METHODS

Fifty postmenopausal women (mean age 78.8 ± 5.3 years) who had existing adipose measurements via dual x-ray absorptiometry (DXA) were selected from the extremes of VAT: n = 25 with low VAT area (45.6 ± 12.5 cm) and n = 25 with high VAT area (177.5 ± 31.3 cm). Dietary intake used to estimate the Healthy Eating Index (HEI) score was assessed with a food frequency questionnaire. Plasma LPS, LPS-binding protein (LBP), anti-LPS antibodies, anti-flagellin antibodies, and anti-lipoteichoic acid (LTA) antibodies were measured by ELISA. Metagenomic sequencing was performed on fecal DNA. Female C57BL/6 mice consuming a high-fat or low-fat diet were treated with 0.4 mg/kg diet-derived fecal isolated LPS modeling metabolic endotoxemia, and metabolic outcomes were measured after 6 weeks.

RESULTS

Women in the high VAT group showed increased Proteobacteria abundance and a lower Firmicutes/Bacteroidetes ratio. Plasma LBP concentration was positively associated with VAT area. Plasma anti-LPS, anti-LTA, and anti-flagellin IgA antibodies were significantly correlated with adiposity measurements. Women with high VAT showed significantly elevated LPS-expressing bacteria compared to low VAT women. Gut bacterial species that showed significant associations with both adiposity and inflammation (anti-LPS IgA and LBP) were Proteobacteria (Escherichia coli, Shigella spp., and Klebsiella spp.) and Veillonella atypica. Healthy eating index (HEI) scores negatively correlated with % body fat and anti-LPS IgA antibodies levels. Preclinical murine model showed that high-fat diet-fed mice administered a low-fat diet fecal-derived LPS displayed reduced body weight, decreased % body fat, and improved glucose tolerance test parameters when compared with saline-injected or high-fat diet fecal-derived LPS-treated groups consuming a high-fat diet.

CONCLUSIONS

Increased VAT in postmenopausal women is associated with elevated gut Proteobacteria abundance and immunogenic metabolic endotoxemia markers. Low-fat diet-derived fecal-isolated LPS improved metabolic parameters in high-fat diet-fed mice giving mechanistic insights into potential pro-health signaling mediated by under-acylated LPS isoforms. Video Abstract.

摘要

背景

肥胖,尤其是腹部肥胖,与多种慢性疾病的发病风险增加有关。肥胖、衰老和绝经都会导致肠道微生物组发生不同的变化。肥胖会因脂多糖(LPS)水平升高而导致慢性低度炎症,这种情况被称为“代谢性内毒素血症”。我们在一组老年绝经后妇女中研究了内脏脂肪组织(VAT)面积、循环内毒素血症标志物和肠道细菌微生物组之间的关系。

方法

从通过双能 X 线吸收法(DXA)进行的现有脂肪测量中选择 50 名绝经后妇女(平均年龄 78.8±5.3 岁),这些妇女处于 VAT 的极值:n=25 名 VAT 面积低(45.6±12.5 cm)和 n=25 名 VAT 面积高(177.5±31.3 cm)。通过食物频率问卷评估用于估计健康饮食指数(HEI)评分的饮食摄入量。通过 ELISA 测量血浆 LPS、LPS 结合蛋白(LBP)、抗 LPS 抗体、抗鞭毛抗体和抗脂磷壁酸(LTA)抗体。对粪便 DNA 进行宏基因组测序。用 0.4 mg/kg 饮食衍生粪便分离 LPS 处理食用高脂肪或低脂肪饮食的雌性 C57BL/6 小鼠,模拟代谢性内毒素血症,并在 6 周后测量代谢结果。

结果

VAT 较高组的妇女表现出变形菌丰度增加和厚壁菌门/拟杆菌门比值降低。血浆 LBP 浓度与 VAT 面积呈正相关。血浆抗 LPS、抗 LTA 和抗鞭毛 IgA 抗体与肥胖测量值显著相关。与 VAT 较低的女性相比,VAT 较高的女性 LPS 表达细菌显著升高。与肥胖和炎症均显著相关的肠道细菌种类(抗 LPS IgA 和 LBP)为变形菌(大肠杆菌、志贺氏菌属和克雷伯氏菌属)和韦荣球菌属。健康饮食指数(HEI)评分与体脂百分比和抗 LPS IgA 抗体水平呈负相关。临床前小鼠模型表明,用高脂肪饮食喂养并给予低脂肪饮食粪便衍生 LPS 的小鼠与给予生理盐水或高脂肪饮食粪便衍生 LPS 处理的继续食用高脂肪饮食的组相比,体重减轻、体脂百分比降低和改善葡萄糖耐量试验参数。

结论

绝经后妇女 VAT 增加与肠道变形菌丰度增加和免疫原性代谢性内毒素血症标志物有关。低脂肪饮食衍生的粪便分离 LPS 改善了高脂肪饮食喂养的小鼠的代谢参数,为潜在的低酰化 LPS 异构体介导的有益健康信号提供了机制见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e393/11453046/909228c45fd3/40168_2024_1901_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e393/11453046/ab59e2d78ace/40168_2024_1901_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e393/11453046/ee538a455274/40168_2024_1901_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e393/11453046/c543329fe3d2/40168_2024_1901_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e393/11453046/39c94f8006d3/40168_2024_1901_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e393/11453046/8987fd13994f/40168_2024_1901_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e393/11453046/42680d55df83/40168_2024_1901_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e393/11453046/909228c45fd3/40168_2024_1901_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e393/11453046/ab59e2d78ace/40168_2024_1901_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e393/11453046/ee538a455274/40168_2024_1901_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e393/11453046/c543329fe3d2/40168_2024_1901_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e393/11453046/39c94f8006d3/40168_2024_1901_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e393/11453046/8987fd13994f/40168_2024_1901_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e393/11453046/42680d55df83/40168_2024_1901_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e393/11453046/909228c45fd3/40168_2024_1901_Fig7_HTML.jpg

相似文献

1
Visceral adiposity in postmenopausal women is associated with a pro-inflammatory gut microbiome and immunogenic metabolic endotoxemia.绝经后妇女的内脏脂肪与促炎的肠道微生物组和免疫原性代谢内毒素血症有关。
Microbiome. 2024 Oct 4;12(1):192. doi: 10.1186/s40168-024-01901-1.
2
Visceral adiposity and inflammatory bowel disease.内脏肥胖与炎症性肠病。
Int J Colorectal Dis. 2021 Nov;36(11):2305-2319. doi: 10.1007/s00384-021-03968-w. Epub 2021 Jun 9.
3
Associations of the Dietary Inflammatory Index with total adiposity and ectopic fat through the gut microbiota, LPS, and C-reactive protein in the Multiethnic Cohort-Adiposity Phenotype Study.多民族队列-肥胖表型研究中,饮食炎症指数通过肠道微生物群、LPS 和 C-反应蛋白与总肥胖和异位脂肪的相关性。
Am J Clin Nutr. 2022 May 1;115(5):1344-1356. doi: 10.1093/ajcn/nqab398.
4
The association between reproductive history and abdominal adipose tissue among postmenopausal women: results from the Women's Health Initiative.绝经后女性生殖史与腹部脂肪组织之间的关联:来自女性健康倡议的结果。
Hum Reprod. 2024 Aug 1;39(8):1804-1815. doi: 10.1093/humrep/deae118.
5
Bovine α-lactalbumin hydrolysates ameliorate obesity-associated endotoxemia and inflammation in high-fat diet-fed mice through modulation of gut microbiota.牛α-乳白蛋白水解物通过调节肠道微生物群改善高脂肪饮食喂养小鼠的肥胖相关内毒素血症和炎症。
Food Funct. 2019 Jun 19;10(6):3368-3378. doi: 10.1039/c8fo01967c.
6
Probiotic and Muscadine Grape Extract Interventions Shift the Gut Microbiome and Improve Metabolic Parameters in Female C57BL/6 Mice.益生菌和麝香葡萄提取物干预可改变肠道微生物群并改善雌性 C57BL/6 小鼠的代谢参数。
Cells. 2023 Nov 10;12(22):2599. doi: 10.3390/cells12222599.
7
Early-life dietary exposures mediate persistent shifts in the gut microbiome and visceral fat metabolism.早期生活饮食暴露介导肠道微生物组和内脏脂肪代谢的持久变化。
Am J Physiol Cell Physiol. 2023 Mar 1;324(3):C644-C657. doi: 10.1152/ajpcell.00380.2021. Epub 2022 Jul 18.
8
Gut Microbiota Mediates the Protective Effects of Dietary Capsaicin against Chronic Low-Grade Inflammation and Associated Obesity Induced by High-Fat Diet.肠道微生物群介导膳食辣椒素对高脂饮食诱导的慢性低度炎症和相关肥胖的保护作用。
mBio. 2017 May 23;8(3):e00470-17. doi: 10.1128/mBio.00470-17.
9
Phlorizin ameliorates obesity-associated endotoxemia and insulin resistance in high-fat diet-fed mice by targeting the gut microbiota and intestinal barrier integrity.根皮苷通过靶向肠道微生物群和肠道屏障完整性改善高脂肪饮食喂养小鼠的肥胖相关内毒素血症和胰岛素抵抗。
Gut Microbes. 2020 Nov 9;12(1):1-18. doi: 10.1080/19490976.2020.1842990.
10
Association of adiposity evaluated by anthropometric, BIA, and DXA measures with cardiometabolic risk factors in nonobese postmenopausal women: the CoLaus/OsteoLaus cohort.采用人体测量学、生物阻抗分析和双能 X 线吸收法评估的肥胖与非肥胖绝经后女性心血管代谢危险因素的关系:CoLaus/OsteoLaus 队列研究。
Menopause. 2022 Jan 24;29(4):450-459. doi: 10.1097/GME.0000000000001930.

引用本文的文献

1
The balance between proinflammatory, "bad", and immunomodulatory, "good", lipopolysaccharide for understanding gut-derived systemic inflammation.促炎“不良”脂多糖与免疫调节“良好”脂多糖之间的平衡对于理解肠道源性全身炎症的意义。
Front Immunol. 2025 Jul 9;16:1588129. doi: 10.3389/fimmu.2025.1588129. eCollection 2025.
2
Multi-omics analyses the effect of Bifidobacterium longum subsp. longum BL21 supplementation on overweight and obese subjects: a randomized, double-blind, placebo-controlled study.多组学分析长双歧杆菌亚种长双歧杆菌BL21补充剂对超重和肥胖受试者的影响:一项随机、双盲、安慰剂对照研究。
Nutr Metab (Lond). 2025 Jul 17;22(1):79. doi: 10.1186/s12986-025-00969-2.
3

本文引用的文献

1
Intestinal Microbiota Influence Doxorubicin Responsiveness in Triple-Negative Breast Cancer.肠道微生物群影响三阴性乳腺癌对多柔比星的反应性。
Cancers (Basel). 2022 Oct 4;14(19):4849. doi: 10.3390/cancers14194849.
2
Spotlight on the Gut Microbiome in Menopause: Current Insights.更年期肠道微生物群研究聚焦:当前见解
Int J Womens Health. 2022 Aug 10;14:1059-1072. doi: 10.2147/IJWH.S340491. eCollection 2022.
3
The gut microbiome as a modulator of healthy ageing.肠道微生物组作为健康衰老的调节剂。
Gut microbiota and serum metabolomics unveil the role of Phellinus ribis polysaccharides in improving Alzheimer's disease symptoms in senescence-accelerated mice.
肠道微生物群和血清代谢组学揭示了桑黄多糖在改善衰老加速小鼠阿尔茨海默病症状中的作用。
Metab Brain Dis. 2025 May 30;40(5):215. doi: 10.1007/s11011-025-01632-8.
4
The gut microbiota in menopause: Is there a role for prebiotic and probiotic solutions?更年期的肠道微生物群:益生元和益生菌解决方案能发挥作用吗?
Post Reprod Health. 2025 May 7:20533691251340491. doi: 10.1177/20533691251340491.
5
MASLD: Prevalence, Mechanisms, and Sex-Based Therapies in Postmenopausal Women.绝经后女性的代谢功能障碍相关脂肪性肝病:患病率、发病机制及基于性别的治疗方法
Biomedicines. 2025 Apr 2;13(4):855. doi: 10.3390/biomedicines13040855.
6
Obesity: pathophysiology and therapeutic interventions.肥胖症:病理生理学与治疗干预措施
Mol Biomed. 2025 Apr 25;6(1):25. doi: 10.1186/s43556-025-00264-9.
Nat Rev Gastroenterol Hepatol. 2022 Sep;19(9):565-584. doi: 10.1038/s41575-022-00605-x. Epub 2022 Apr 25.
4
Diet impacts triple-negative breast cancer growth, metastatic potential, chemotherapy responsiveness, and doxorubicin-mediated cardiac dysfunction.饮食会影响三阴性乳腺癌的生长、转移潜能、化疗反应性以及多柔比星引起的心脏功能障碍。
Physiol Rep. 2022 Apr;10(8):e15192. doi: 10.14814/phy2.15192.
5
Antihypertensive Therapy by ACEI/ARB Is Associated With Intestinal Flora Alterations and Metabolomic Profiles in Hypertensive Patients.血管紧张素转换酶抑制剂/血管紧张素Ⅱ受体阻滞剂进行的降压治疗与高血压患者肠道菌群改变及代谢组学特征相关。
Front Cell Dev Biol. 2022 Mar 23;10:861829. doi: 10.3389/fcell.2022.861829. eCollection 2022.
6
Gut microbiota in patients with obesity and metabolic disorders - a systematic review.肥胖和代谢紊乱患者的肠道微生物群——一项系统综述。
Genes Nutr. 2022 Jan 29;17(1):2. doi: 10.1186/s12263-021-00703-6.
7
Metabolic endotoxemia is dictated by the type of lipopolysaccharide.代谢性内毒素血症取决于脂多糖的类型。
Cell Rep. 2021 Sep 14;36(11):109691. doi: 10.1016/j.celrep.2021.109691.
8
Diet Alters Entero-Mammary Signaling to Regulate the Breast Microbiome and Tumorigenesis.饮食改变肠-乳腺信号以调节乳腺微生物组和肿瘤发生。
Cancer Res. 2021 Jul 15;81(14):3890-3904. doi: 10.1158/0008-5472.CAN-20-2983. Epub 2021 Jun 3.
9
Diet, obesity, and the gut microbiome as determinants modulating metabolic outcomes in a non-human primate model.饮食、肥胖和肠道微生物组作为决定因素,调节非人类灵长类动物模型中的代谢结果。
Microbiome. 2021 May 5;9(1):100. doi: 10.1186/s40168-021-01069-y.
10
The Interplay between the Gut Microbiome and the Immune System in the Context of Infectious Diseases throughout Life and the Role of Nutrition in Optimizing Treatment Strategies.肠道微生物组与免疫系统在整个生命周期感染性疾病中的相互作用,以及营养在优化治疗策略中的作用。
Nutrients. 2021 Mar 9;13(3):886. doi: 10.3390/nu13030886.